aTyr Pharma Inc (NASDAQ:LIFE) Investor Investigation Concerning Potential Securities Laws Violations Announced

If you purchased shares of aTyr Pharma Inc (NASDAQ:LIFE), you have certain options and you should contact the Shareholders Foundation, Inc.

To have your information reviewed for options and to recieve notifications about this investigation, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Company Name(s): 
aTyr Pharma
Affected Securities: 
NASDAQ: LIFE

April 15, 2016 (Shareholders Foundation) - An investigation on behalf of investors of aTyr Pharma Inc (NASDAQ:LIFE) shares over potential securities laws violations by aTyr Pharma and certain of its directors and officers in connection certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of aTyr Pharma Inc (NASDAQ:LIFE) concerning whether a series of statements by aTyr Pharma regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

aTyr Pharma Inc went public in May 2015 and shares of aTyr Pharma Inc (NASDAQ:LIFE) rose to as high as $27.88 per share in June 2015. Since then shares of aTyr Pharma Inc (NASDAQ:LIFE) have declined significantly. In fact, shares of aTyr Pharma Inc declined to as low as $3.03 per share on April 8, 2016.